ClinicalTrials.Veeva

Menu
D

DelRicht Research | Gulfport Memorial

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elismetrep
K-304

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Enrolling
Acute Migraine
Drug: Placebo
Drug: Elismetrep

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep
Locations recently updated

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Active, not recruiting
Influenza
Combination Product: MK-1406
Combination Product: Placebo

Trial sponsors

K
Moderna logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems